Prevention translation supplement award
This category is not open to applications, Details are provided for information only. Please see Financial administration for updated information on scientific and financial reporting requirements and policies.
The proposed work must result from a peer reviewed grant to be eligible for funding under this supplemental award. This competition was previously open to current Canadian Cancer Society research grant holders but this eligibility has been expanded to allow any investigator with current or prior funding from any recognized peer-review funding agency to apply.
Investigators may propose collaborations with different research institutions, as appropriate. Research proposals must demonstrate an evaluable impact on increasing understanding of and action around cancer prevention. The supplement award will support pilot studies that meet the following conditions:
- The original grant involves identifying or quantifying a cancer risk factor cause or behaviour change that could be modified through an intervention in the human population;
- Costs for the proposed intervention cannot have been included in the original grant;
- The Principal Investigator (PI) for the supplement award must be a named investigator on the original grant. If the PI of the original grant is not a listed participant on the supplement award, a letter of acknowledgement and support for the proposed pilot study must be provided to the CCS with the full application.
Abstract registration must be completed in order to submit a full application.
The purpose of this funding initiative is to stimulate the translation of basic research, epidemiological research and observational research findings into cancer prevention action by supporting pilot studies of interventions derived from a currently funded research project (referred to as “the original grant”). Priority areas identified by the Canadian Cancer Society include, but are not limited to:
- tobacco control
- occupational and environmental carcinogens (O&E)
- UV radiation exposure
- healthy eating and physical activity
- basic research including better understanding of cancer etiology and gene-based studies related to risk reduction and prevention
These projects are expected to take existing evidence and transition it into an intervention research project. A central focus of this funding program and the reason for its prioritization by the Canadian Cancer Society End 1 Development Committee is to provide an opportunity to build on existing cancer research findings and turn them into cancer prevention action.
Applications are invited from any investigator with current or prior funding from any recognized peer-review funding agency across all disciplines to submit pilot studies that will translate their research findings into identifying effective interventions that reduce the cancer incidence in the human population. Examples of studies that may be appropriate for this initiative include (but are not limited to):
- early phase studies to determine the appropriate dosage and side effects of a promising intervention strategy derived from the original grant, which could include pharmacologic agents (e.g., chemoprevention) or behaviours (e.g., physical activity)
- pilot studies to examine the feasibility (e.g., recruitment, accrual, compliance, effect size) of an intervention derived from the original grant
- pilot cancer prevention interventions in human populations that further examine the use of biomarkers and predictors of outcomes identified in the original grant
- pilot cancer prevention interventions in groups at high risk based on findings of the original grant (e.g., genetic predisposition to cancer)
Investigators applying for these supplement awards are strongly encouraged to establish appropriate collaborations to secure unique expertise related to the design and implementation of cancer prevention interventions. These collaborations may involve, for example, experts in behavioural science and/or oncology practitioners.
Individual supplement awards will be funded to a maximum of $200,000 over a two-year period. Budget requests can include (within the funding cap) a request for permanent equipment of up to $35,000.
The time-frame and associated expenses must be clearly justified in the budget. The grant is non-renewable.
Peer review panel
A single multidisciplinary peer review committee will be assembled for this competition. The peer review committee will consist of scientific experts, along with community representatives to provide patient/survivor/caregiver perspectives.
Registration is mandatory and will require applicant details (Principal Investigator(s)/Co-Applicants/Additional Authors), scientific abstract, keywords, suggested reviewers and research tracking information.
Any significant changes to the proposed project or applicant team after the Abstract registration deadline should be communicated to the CCS (email@example.com) as soon as they are known.
The application is accessible through the CCS online research application system EGrAMS. All applications must meet the eligibility requirements.
Full application structure
The proposal will contain no more than 5 pages of single-spaced text and 5 pages of figures/tables/charts and associated legends. Specific guidelines for the online application are available.
When preparing the full application, applicants are required to provide the following:
- a detailed outline of the work to be performed and how the proposed supplement will transition and build on the research findings of the original grant
- an indication of which member(s) of the research team will be responsible for each aspect of the project including a detailed rationale for their inclusion in the project
- a scientific outline that clearly states the aims of the project(s) including any previous work done in the area, experimental design, methods and analysis
- relevance of the project to cancer prevention including the impact research results will have on the burden of cancer or the advancement of cancer prevention research
- a detailed description of the actual products expected to result from the project
- a detailed plan for the dissemination of the research findings beyond scientific publication, including a knowledge translation and exchange strategy which may include partnerships with policy, program delivery and advocacy experts
- a budget justification related to the supplies, expenses and personnel associated with the research project. This must include the number of personnel required to complete the work and a description of their experience and/or education level. Should equipment be required to complete the research, at least 2 price quotes for each piece of equipment over $10,000 is required
The review committee will prepare written critiques. The review criteria for the written application will include but not necessarily be restricted to the following:
- relevance to the mission of the Canadian Cancer Society
- relevance to the risk reduction and prevention priority areas identified by the Canadian Cancer Society
- scientific merit of the research project for preventing cancer
- qualifications and experience of the investigators responsible for the research components
- innovativeness of the proposed research project
- appropriateness of the methods for the focus of the research
- appropriateness of the knowledge translation and exchange strategy to disseminate research finding s beyond scientific publication
- likelihood that the proposed research will have an impact on moving the field of cancer prevention research forward
- appropriateness of the term and amount of support requested
Multiple applications/multiple sources of funding
It is understood that applications may also be made to other agencies to provide support for grants/programs similar to those submitted to the Canadian Cancer Society. The onus is on the applicant to indicate the extent (or absence) of overlap. Grantees can accept funds from other sources, up to the CCS grant panel recommended amount.
Applicants are reminded to review the eligibility and requirements page for details on scientific and financial reporting, funder acknowledgement, Canadian Cancer Society policies on open access and tobacco related funding.
Last modified on: September 14, 2017